Shisong Han

16PUBLICATIONS
27CO-AUTHORS
Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanometrologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 23, 2026
Target Identification of the Hepatocellular Carcinoma-Specific Aptamer JHIT2e and Construction of Engineered Nanotrains for Synergistic Chemoradiotherapy.

Jiangkun Yu, Xue Lin, Wenshan Huang

|Nov 26, 2025
Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms.

Ding Qi, Yongqing Qin, Haidong Zhu

|Dec 11, 2024
Biodegradable silk fibroin membranes for potential localized treatment of melanoma: optimized preparation and<i>in vitro</i>study.

Mingshuang Zhang, Shisong Han, Ya Wang

|May 03, 2024
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy.

Yongqing Qin, Shisong Han, Yahan Yu

|Apr 19, 2024
Dual-Responsive Nanomedicine Activates Programmed Antitumor Immunity through Targeting Lymphatic System.

Hong Xiao, Xiaoxia Li, Simin Liang

|Oct 24, 2023
Improvement of the effectiveness of sonodynamic therapy: by optimizing components and combination with other treatments.

Xiangting Wang, Xiaohong Xu, Zhe Yang

Pageof 3

Frequent Collaborators

7 joint publications

Xintao Shuai

3 joint publications

Jinsheng Huang

1 joint publications

Zecong Xiao

1 joint publications

Zhenwei Su